Pharma publication celebrates 'new blockbuster heart disease market'
https://www.fiercepharma.com/marketi...myopathy-cases
Pfizer, Alnylam and BMS take note: The US is poised to see 'a staggering number' of cardiomyopathy cases this decade
By Ben Adams
Jul 8, 2022 10:00am
https://qtxasset.com/cdn-cgi/image/w...VDNwIj5Ih5je6V
_____________________________
Pharma publication celebrates 'new blockbuster heart disease market'
by: WorldTribune.com 07/13/2022 Source: WorldTribune.com

